Endometrium kanserinde lenf nodu metastazını öngörmede preoperatif kontrastlı bilgisayarlı tomografinin tanısal performansı: 408 hastalık tek merkezli bir çalışma

Öz

Amaç: Bu çalı%mada, endometrium kanseri hastalarında preoperatif bilgisayarlı tomografide (BT) kısa aks çapı ≥10 mm olan lenf nodlarının, patolojik lenf nodu metastazını (LNM) öngörmedeki tanısal performansının değerlendirilmesi amaçlandı. Gereç ve Yöntemler: Bu retrospektif tek merkezli çalı%maya, sentinel lenf nodu (SLN) haritalaması ve/veya sistematik lenfadenektomi uygulanan 408 endometrium kanseri hastası dahil edildi. Preoperatif kontrastlı BT incelemelerinde kısa aks çapı ≥10 mm olan lenf nodları pozitif olarak kabul edildi. Patolojik LNM, SLN ve/veya lenfadenektomi örneklerinde metastaz saptanması olarak tanımlandı. Duyarlılık, özgüllük, pozitif öngörü değeri (PPV), negatif öngörü değeri (NPV), doğruluk ve olasılık oranları (OR) hesaplandı. Bulgular: Patolojik LNM 36 hastada (%8.8) saptandı. BT’de 39 hastada lenf nodu pozitif (≥10 mm) izlendi. BT’nin LNM saptamadaki duyarlılığı %50.0, özgüllüğü %94.4 olarak bulundu. PPV %46.2, NPV %95.1 ve genel tanısal doğruluk %90.5 idi. BT pozitifliği ile patolojik LNM arasında anlamlı ili%ki saptandı (OR 16.7, 95% CI: 8.1–34.3, p < 0.001). Ancak LNM saptanan hastaların %50’sinde BT’de büyümü% lenf nodu izlenmedi. Çok deği%kenli analizde, BT pozitifliğinin LVSI ve histolojik tip için düzeltme yapıldıktan sonra da lenf nodu metastazı ile bağımsız olarak ili%kili olduğu gösterildi (düzeltilmi% OR: 2.83, %95 GA: 1.10–7.29, p = 0.031). Sonuç: Kısa aks ≥10 mm kriteri kullanılarak yapılan preoperatif BT değerlendirmesi, EK’de LNM saptamada yüksek özgüllük ve negatif öngörü değerine sahip olmakla birlikte, duyarlılığı sınırlıdır. BT pozitifliği nodal metastaz olasılığını belirgin %ekilde artırsa da, negatif BT mikroskopik metastazı güvenilir biçimde dı%lamamaktadır. Bu nedenle cerrahi nodal değerlendirme stratejileri yalnızca BT bulgularına dayandırılmamalıdır.

Anahtar Kelimeler

• Endometrium Neoplazileri
• Lenfatik Metastaz
• Bilgisayarlı Tomografi
• Duyarlılık ve Özgüllük
• Tanısal Görüntüleme

Diagnostic performance of preoperative contrast-enhanced computed tomography in predicting lymph node metastasis in endometrial cancer: a single-center study of 408 patients

Öz

Aim: To evaluate the diagnostic performance of preoperative computed tomography (CT) using a short-axis diameter threshold of ≥10 mm for predicting lymph node metastasis (LNM) in patients with endometrial cancer. Material and Methods: This retrospective single-center study included 408 patients with endometrial cancer who underwent primary surgical treatment with sentinel lymph node (SLN) mapping and/or systematic lymphadenectomy. Preoperative contrast-enhanced CT scans were reviewed, and lymph nodes with a short-axis diameter ≥10 mm were considered positive. Pathological LNM was defined as metastatic involvement in SLN and/or lymphadenectomy specimens. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, and odds ratios (ORs) were calculated. Results: Pathological LNM was identified in 36 patients (8.8%). CT detected lymph node enlargement (≥10 mm) in 39 patients. The sensitivity and specificity of CT for detecting LNM were 50.0% and 94.4%, respectively. PPV was 46.2%, NPV was 95.1%, and overall diagnostic accuracy was 90.5%. CT positivity was significantly associated with pathological LNM (OR 16.7, 95% CI: 8.1–34.3, p < 0.001). However, 18 patients with LNM (50%) had no radiologically enlarged lymph nodes on CT. In multivariable analysis, CT positivity remained independently associated with LNM after adjustment for LVSI and histological type (adjusted OR: 2.83, 95% CI: 1.10–7.29, p = 0.031). Conclusion: Preoperative CT using a ≥10 mm short-axis criterion demonstrates high specificity and negative predictive value but limited sensitivity for detecting lymph node metastasis in endometrial cancer. While CT positivity markedly increases the likelihood of nodal metastasis, a negative CT does not reliably exclude microscopic disease. Therefore, surgical nodal assessment strategies should not rely solely on CT findings.

Anahtar Kelimeler

• endometrial neoplasms
• lymphatic metastasis
• computed tomography
• sensitivity and specificity
• diagnostic imaging

Kaynakça

1. Qiu S, Jiang S, Ye Q, Yang Y, Li X. Global trends and geographical disparities in the incidence of uterine cancer from 1990 to 2021. Eur J Obstet Gynecol Reprod Biol. 2025;311:114066. doi:10.1016/j.ejogrb.2025.114066
2. Menendez-Santos M, Gonzalez-Baerga C, Taher D, Waters R, Virarkar M, Bhosale P. Endometrial Cancer: 2023 Revised FIGO Staging System and the Role of Imaging. Cancers. 2024;16(10):1869. doi:10.3390/cancers16101869
3. Concin N, Matias-Guiu X, Cibula D, et al. ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025. Lancet Oncol. 2025;26(8):e423-e435. doi:10.1016/S1470-2045(25)00167-6
4. Oaknin A, Bosse TJ, Creutzberg CL, et al. Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(9):860-877. doi:10.1016/j.annonc.2022.05.009
5. Holm J, Dias AH, Gerke O, et al. Diagnostic Accuracy and Interrater Agreement of FDG-PET/CT Lymph Node Staging in High-Risk Endometrial Cancer: The SENTIREC-Endo Study. Cancers. 2025;17(14):2396. doi:10.3390/cancers17142396
6. Park JY, Kim EN, Kim DY, et al. Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer. Gynecol Oncol. 2008;108(3):486-492. doi:10.1016/j.ygyno.2007.11.044
7. Kim HJ, Cho A, Yun M, Kim YT, Kang WJ. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Ann Nucl Med. 2016;30(2):104-113. doi:10.1007/s12149-015-1037-8
8. Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging. Gynecol Oncol. 2008;109(1):11-18. doi:10.1016/j.ygyno.2008.01.023

9. Höhn AK, Brambs CE, Hiller GGR, May D, Schmoeckel E, Horn LC. 2020 WHO Classification of Female Genital Tumors. Geburtshilfe Frauenheilkd. 2021;81(10):1145-1153. doi:10.1055/a-1545-4279
10. Yilmaz A, Yilmaz F, Şahi̇N HÖ, Öz Atalay F, Uysal D, Ozan H. Comparing the efficacy of imaging techniques in detecting myometrial invasion, cervical involvement and pelvic lymph-nodal metastasis in endometrial cancer. Ege Tıp Derg. 2022 Dec 12;61(4):647–50.
11. Bi Q, Chen Y, Wu K, et al. The Diagnostic Value of MRI for Preoperative Staging in Patients with Endometrial Cancer: A Meta-Analysis. Acad Radiol. 2020;27(7):960-968. doi:10.1016/j.acra.2019.09.018
12. Antonsen SL, Jensen LN, Loft A, et al. MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer — A multicenter prospective comparative study. Gynecol Oncol. 2013;128(2):300-308. doi:10.1016/j.ygyno.2012.11.025
13. Atri M, Zhang Z, Dehdashti F, et al. Utility of PET/CT to Evaluate Retroperitoneal Lymph Node Metastasis in High-Risk Endometrial Cancer: Results of ACRIN 6671/GOG 0233 Trial. Radiology. 2017;283(2):450-459. doi:10.1148/radiol.2016160200
14. Berek JS, Matias‐Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023. Int J Gynecol Obstet. 2023;162(2):383-394. doi:10.1002/ijgo.14923
15. Öncü HN, Ege G, Öztürk N, et al. The relationship between lymph node metastasis and immunohistochemical molecular subtypes in endometrial cancer: A cohort study of 339 patients. J Obstet Gynaecol Res. 2025;51(9):e70065. doi:10.1111/jog.70065
16. Jamieson A, Thompson EF, Huvila J, et al. Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases. Gynecol Oncol. 2022;165(2):376-384. doi:10.1016/j.ygyno.2022.01.025
17. Meng Y. Clinicopathological characteristics of endometrial carcinoma with different molecular subtypes and their correlation with lymph node metastasis. Am J Cancer Res. 2024;14(8):3994-4003. doi:10.62347/FPUJ8382